1. Guest, the 'News in Brief' for the week beginning 22nd February 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31. 2020, Pothineni et al

Discussion in 'Infections: Lyme, Candida, EBV ...' started by Andy, Mar 19, 2020.

  1. Andy

    Andy Committee Member & Outreach

    Messages:
    12,121
    Likes Received:
    87,231
    Location:
    Hampshire, UK
    Open access, https://www.nature.com/articles/s41598-020-59600-4
     
    dadouv47, shak8, alktipping and 3 others like this.
  2. 5vforest

    5vforest Established Member (Voting Rights)

    Messages:
    45
    Likes Received:
    230
    Location:
    San Francisco, CA
    There are a lot of people suffering from chronic Lyme Disease who are banking on Azlocillin being a silver bullet cure. I am pretty skeptical.

    I am really unclear as to why Azlocillin was chosen in this study, besides the fact that the researchers have a patent for its reformulation into an oral drug.

    There are probably a lot of compounds that will eradicate Bb in vitro. Remember, Disulfiram was said to do this as well, and it's already available for use. But there are a lot of people who remain sick, with some evidence of persistent infection, despite a course of Dilsulfiram.

    There are a lot of remaining questions for those of us suffering with chronic effects of tick borne infections and I am dubious that Azlocillin is going to change much.
     

Share This Page